Page last updated: 2024-08-24

tangeretin and Cancer of Ovary

tangeretin has been researched along with Cancer of Ovary in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arafa, el-SA; Barakat, BM; El-Mahdy, MA; Wani, AA; Wani, G; Zhao, Q; Zhu, Q	1

Other Studies

1 other study(ies) available for tangeretin and Cancer of Ovary

Article	Year
Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer research, 2009, Dec-01, Volume: 69, Issue:23 Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cell Growth Processes; Cisplatin; Down-Regulation; Drug Administration Schedule; Drug Synergism; Female; Flavones; G2 Phase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Oncogene Protein v-akt; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Signal Transduction	2009

Article

Year

Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway.

Cancer research, 2009, Dec-01, Volume: 69, Issue:23

Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Division; Cell Growth Processes; Cisplatin; Down-Regulation; Drug Administration Schedule; Drug Synergism; Female; Flavones; G2 Phase; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Oncogene Protein v-akt; Ovarian Neoplasms; Phosphatidylinositol 3-Kinases; Signal Transduction

2009